Topics

Photo
• 17.09.2025 • TopicsChemistry

Back to Basics for Chemical Suppliers

Chemical customers are willing to pay a premium if their product and service needs are fully met, presenting an opportunity for suppliers to strengthen relationships and generate new value.

Photo
16.09.2025 • TopicsChemistry

Plastics and the Value Of Sustainability

How designers can help make sustainable materials both attractive and desirable, emphasizing the importance of collaboration among industry professionals to create a new aesthetic language for sustainability.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
25.04.2025 • TopicsStrategy

The Trump Tariffs

China’s chemical industry is diversifying markets, boosting innovation, and strengthening supply chains to counter US tariffs and maintain export resilience.

Photo
19.03.2025 • TopicsChemistry

Making Waves

Global water scarcity is now urgent due to climate change, population growth, and unsustainable practices. 700 million people could be displaced by 2030, warns UNICEF, especially in water-intensive industries like personal care, textiles, food production, and paint.

Photo
19.03.2025 • TopicsDigitalization

From Data Silos to a Digital Future

Chemical producers in Germany are grappling with rising costs, high energy prices, global competition, and an impending knowledge gap due to demographic shifts. Kuraray, a global leader in specialty chemicals, is addressing these challenges with a comprehensive digitalization strategy.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

1822 more Topics

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.